Micro Therapeutics and Abbott bring back direct selling in US:
This article was originally published in Clinica
Micro Therapeutics has re-established a direct sales force in the US and Canada for its peripheral vascular blood clot therapy products, while Abbott Laboratories, formerly in charge of marketing and selling for the infusion catheter, guidewire and thrombolytic devices company, retains physical distribution. The move comes just weeks after the appointment of a new executive vice-president of marketing and sales at Irvine, California-based Micro Therapeutics. The Abbott deal was in place since 1998.